Slides
Page 1
Sareum Specialists in Small Molecule Drug Development Final Results for the Year Ending 30 June 2021 2 November 2021 Dr Tim Mitchell , CEO & Co - Founder Dr John Reader , CSO and Co - Founder www.sareum.co.uk
Loading workspace
Sareum Specialists in Small Molecule Drug Development Final Results for the Year Ending 30 June 2021 2 November 2021 Dr Tim Mitchell , CEO & Co - Founder Dr John Reader , CSO and Co - Founder www.sareum.co.uk
Your watchlist and earnings event details are available after you sign in.